Study of Epratuzumab in Systemic Lupus Erythematosus

Summary

Epratuzumab is an investigational antibody designed to help treat Systemic Lupus Erythematosus (SLE). The purpose of the study is to obtain additional long-term information regarding the safety and efficacy of continued maintenance-cycle administrations of Epratuzumab.

Timeline

Start

2006-06

Primary completion

2012-01

Completion

2012-01

Drugs

Indications